Catalyst Wire Dossier Catalyst Wire Dossier

NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

nicardipine hydrochloride · FRESENIUS KABI USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, covering 2026-08-04 to 2026-08-04. Get the full timeline:

Most recent: FDA Approved: NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE — Original Application (FRESENIUS KABI USA)

See pricing